We are live on ! Find out more
ALT icon

Altimmune
ALT

128 hedge funds and large institutions have $1.03B invested in Altimmune in 2022 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 38 increasing their positions, 35 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

719% more call options, than puts

Call options by funds: $60M | Put options by funds: $7.33M

61% more capital invested

Capital invested by funds: $640M → $1.03B (+$391M)

20% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 30

5% more funds holding

Funds holding: 122 → 128 (+6)

9% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 35

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

7.09% less ownership

Funds ownership: 102.32% → 95.24% (-7.1%)

Holders
128
Holders Change
+6
Holders Change %
+4.92%
% of All Funds
2.06%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
36
Increased
38
Reduced
35
Closed
30
Calls
$60M
Puts
$7.33M
Net Calls
+$52.7M
Net Calls Change
+$22.7M

Top Buyers

1
State Street
State Street
Massachusetts
+$28.3M
2
APM
Avidity Partners Management
Texas
+$14.7M
3
PAMS
Pictet Asset Management (Switzerland)
Switzerland
+$12.1M
4
Citadel Advisors
Citadel Advisors
Florida
+$11.6M
5
Jennison Associates
Jennison Associates
New York
+$8.39M

Top Sellers

1
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$49.5M
2
DCM
Driehaus Capital Management
Illinois
-$15.6M
3
BBA
Baker Bros. Advisors
New York
-$12.5M
4
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$9.64M
5
LGM
Logos Global Management
California
-$9.58M
Name Holding Trade Value Shares
Change 		Change in
Stake
HNB
126
Huntington National Bank
Ohio
$33 – – –
ME
127
McIlrath & Eck
Washington
$33 +$22 +2 New
DCM
128
Driehaus Capital Management
Illinois
– -$15.6M -1,222,586 Closed
LGM
129
Logos Global Management
California
– -$9.58M -750,000 Closed
BC
130
Boxer Capital
California
– -$6.38M -500,000 Closed
GTC
131
Ghost Tree Capital
New York
– -$5.55M -435,000 Closed
VA
132
VR Adviser
New York
– -$4.72M -369,306 Closed
EI
133
EAM Investors
California
– -$2.62M -205,167 Closed
GPCM
134
Granite Point Capital Management
Massachusetts
– -$2.3M -180,000 Closed
CSS
135
Cubist Systematic Strategies
Connecticut
– -$2.18M -170,947 Closed
Connor, Clark & Lunn Investment Management (CC&L)
136
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
– -$1.63M -127,562 Closed
ACP
137
Acuta Capital Partners
California
– -$1.6M -125,000 Closed
EGI
138
EAM Global Investors
California
– -$1.08M -84,821 Closed
SSA
139
Schonfeld Strategic Advisors
New York
– -$742K -58,102 Closed
JGC
140
J. Goldman & Co
New York
– -$714K -55,935 Closed
CCIA
141
Campbell & Co Investment Adviser
Maryland
– -$502K -39,317 Closed
Wolverine Trading
142
Wolverine Trading
Illinois
– -$429K -38,227 Closed
WMSA
143
Weiss Multi-Strategy Advisers
New York
– -$416K -32,600 Closed
RJA
144
Raymond James & Associates
Florida
– -$405K -31,710 Closed
IMC Chicago
145
IMC Chicago
Illinois
– -$337K -30,014 Closed
AI
146
Atom Investors
Texas
– -$342K -26,818 Closed
BCM
147
Bayesian Capital Management
New York
– -$324K -25,409 Closed
CL
148
CSS LLC
Illinois
– -$231K -20,546 Closed
SEI Investments
149
SEI Investments
Pennsylvania
– -$259K -20,263 Closed
Bank of Montreal
150
Bank of Montreal
Ontario, Canada
– -$391 -20,065 Closed
3 4 5
6
7

ALT Hedge Fund Activity: Q4 2022 in Review

128 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Altimmune (ALT) for Q4 2022, worth a combined $1.03B — up 61% from $640M a quarter earlier.

Buyers outnumbered sellers: 36 funds opened new ALT positions and 30 closed out — a net gain of 6 holders — while 38 added to existing stakes and 35 trimmed.

The largest buyer was State Street, adding an estimated $28.3M. The largest seller was Janus Henderson Group, cutting an estimated $49.5M.

  • 128 institutional investors held Altimmune (ALT) as of Q4 2022, up from 122 in Q3 2022.
  • Funds reported $1.03B of Altimmune stock for Q4 2022, up 61% quarter-over-quarter.
  • 36 funds opened new Altimmune positions in Q4 2022 and 30 closed out, a net change of +6 holders.
  • The largest Altimmune buyer in Q4 2022 was State Street, an estimated $28.3M added.
  • The largest Altimmune seller in Q4 2022 was Janus Henderson Group, an estimated $49.5M sold.

Based on aggregated 13F filings for Q4 2022.